A recent report published by Infinium Global Research on 3D bioprinting market provides an in-depth analysis of segments and sub-segments in the global as well as regional 3D bioprinting industry
Pune, India -- (SBWIRE) -- 11/27/2019 -- The Infinium Global Research analyzes the "3D Bioprinting Market (Technology - Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, and Magnetic 3D Bioprinting; Material - Living Cells, Hydrogels, Extracellular Matrices, and Other Materials; Application - Research Applications, Clinical Applications, and Other Applications; End User - Pharmaceutical & Biotechnology Companies, Research Organizations, and Other End Users): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025". 3D Bioprinting Market size is projected to grow from USD 853.3 Million in 2018 to USD 4,306.6 Million by 2025, at a CAGR of 21.40% during the forecast period.
For More Details Get FREE Sample Pages of this Research Report@ https://www.infiniumglobalresearch.com/reports/sample-request/13155
Lucrative Growth of 3D Bioprinting Industry Owing to Rising Healthcare Initiatives
The increase in the geriatric population and the rise in the prevalence of chronic diseases are the major factors driving the global 3D bioprinting market. Furthermore, an increase in R&D investment is contributing to the growth of the global 3D bioprinting market. Additionally, government initiatives for improving healthcare are also contributing to the growth of the 3D bioprinting market. However, the cost of instruments is hampering the growth of the global 3D bioprinting market. Nonetheless, the trend of personalized medicine is anticipated to provide favorable opportunities for companies in the 3D bioprinting market.
Request a Discount on Standard Prices of this Premium Report @ https://www.infiniumglobalresearch.com/reports/request-discount/13155
Largest Account Held by Sub-Segment Microextrusion Bioprinting Technology
The global 3D bioprinting market is segmented based on technology, material, application, and end-user. The technology segment is further categorized into microextrusion bioprinting, inkjet 3D bioprinting, laser-assisted bioprinting, and magnetic 3D bioprinting. The microextrusion bioprinting segment accounted for the largest share in the global 3D bioprinting market owing to its preciseness and cost-effectiveness. Based on material, the global 3D bioprinting market is further segmented into living cells, hydrogels, extracellular matrices, and other materials.
The applications of 3D bioprinting include research applications, clinical applications, and other applications. The clinical application segment holds a large share of the market. The end-user segment is further classified into pharmaceutical & biotechnology companies, research organizations, and other end-users. The pharmaceutical & biotechnology companies' segment among the end-users dominated the market with a high share in the global 3D bioprinting market. The domination of this segment is attributed to the increasing need for medicines and advantages such as fast and cost-efficient production of bio-drugs using this technology.
Rising Geriatric Population Fuel Growth for 3D Bioprinting in North America
Based on geography, the global 3D bioprinting market is divided into four major regions namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America region dominated the global 3D bioprinting market, accounting for the largest share in the market. The large share of the region attributed to the increase in the geriatric population, the presence of major market players, sophisticated healthcare infrastructure and high investment in R&D to develop 3D printing technology. On the other hand, the 3D Bioprinting market in the Asia Pacific region is anticipated to register the highest rate of growth. The fastest growth of the market in this region attributes to a large population base suffering from chronic diseases, and the increasing number of government initiatives to improve healthcare.
3D Bioprinting Market: Competitive Landscape
The 3D bioprinting market is relatively new and it is highly fragmented in nature with a number of market players competing to hold a leading position in the market. The key players in the market including Organovo Holdings Inc., Cellink AB, Cyfuse Biomedical K.K., 3Dynamics Systems Ltd., Aspect Biosystems Ltd., and others are focusing on strategic collaborations, acquisitions, agreements, and novel product launches to compete in the market. Recently, Aspect Biosystems made a collaboration with the Institute for Technology-Inspired Regenerative Medicine (MERLN) at Maastricht University in the Netherlands to develop kidney tissue by the head of bioprinting research.
Browse Detailed TOC and Description of "3D Bioprinting Market"
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of the 3D Bioprinting.
=> Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2025.
=> Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.